These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16020146)

  • 41. Perceptions of female sexual health and sexual dysfunction in a cohort of urban professional women in Abuja, Nigeria.
    Aisuodionoe-Shadrach OI
    Niger J Clin Pract; 2012; 15(1):80-3. PubMed ID: 22437096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction.
    Quirk FH; Heiman JR; Rosen RC; Laan E; Smith MD; Boolell M
    J Womens Health Gend Based Med; 2002 Apr; 11(3):277-89. PubMed ID: 11988137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation.
    Tierney KD; Facione N; Padilla G; Blume K; Dodd M
    Eur J Oncol Nurs; 2007 Sep; 11(4):298-308. PubMed ID: 17196431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Female androgen insufficiency.
    Bachmann G; Oza D
    Obstet Gynecol Clin North Am; 2006 Dec; 33(4):589-98. PubMed ID: 17116503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testosterone therapy for sexual dysfunction in postmenopausal women.
    Hubayter Z; Simon JA
    Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14).
    Keller A; McGarvey EL; Clayton AH
    J Sex Marital Ther; 2006; 32(1):43-52. PubMed ID: 16234225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Holding onto womanhood: a qualitative study of heterosexual women with sexual desire loss.
    Hinchliff S; Gott M; Wylie K
    Health (London); 2009 Jul; 13(4):449-65. PubMed ID: 19491236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negotiating sexual agency: postmenopausal women's meaning and experience of sexual desire.
    Wood JM; Mansfield PK; Koch PB
    Qual Health Res; 2007 Feb; 17(2):189-200. PubMed ID: 17220390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome measurement in female sexual dysfunction clinical trials: review and recommendations.
    Althof SE; Rosen RC; DeRogatis L; Corty E; Quirk F; Symonds T
    J Sex Marital Ther; 2005; 31(2):153-66. PubMed ID: 15859374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should dyspareunia be retained as a sexual dysfunction in DSM-V? A painful classification decision.
    Binik YM
    Arch Sex Behav; 2005 Feb; 34(1):11-21. PubMed ID: 15772767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of validated questionnaires to assess female sexual dysfunction.
    Jones LR
    World J Urol; 2002 Jun; 20(2):89-92. PubMed ID: 12107538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutoff score of the sexual interest and desire inventory-female for diagnosis of hypoactive sexual desire disorder.
    Clayton AH; Segraves RT; Bakish D; Goldmeier D; Tignol J; van Lunsen RH; Nappi RE; Wunderlich G; Kimura T; Lewis-D'Agostino DJ; Pyke R
    J Womens Health (Larchmt); 2010 Dec; 19(12):2191-5. PubMed ID: 20858040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validated instruments for assessing female sexual function.
    Meston CM; Derogatis LR
    J Sex Marital Ther; 2002; 28 Suppl 1():155-64. PubMed ID: 11898697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased libido in postmenopausal women.
    Murray W
    Nurse Pract Forum; 2000 Dec; 11(4):219-24. PubMed ID: 11220019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life and sexual function in postmenopausal women.
    Nazarpour S; Simbar M; Ramezani Tehrani F; Alavi Majd H
    J Women Aging; 2018; 30(4):299-309. PubMed ID: 29077541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction.
    Nijland E; Davis S; Laan E; Schultz WW
    J Sex Med; 2006 Sep; 3(5):763-777. PubMed ID: 16942521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Applying the Female Sexual Functioning Index to sexual minority women.
    Boehmer U; Timm A; Ozonoff A; Potter J
    J Womens Health (Larchmt); 2012 Apr; 21(4):401-9. PubMed ID: 22136340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part I.
    Derogatis LR; Sand M; Balon R; Rosen R; Parish SJ
    J Sex Med; 2016 Dec; 13(12):1881-1887. PubMed ID: 27743749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The selling of 'female sexual dysfunction'.
    Tiefer L
    J Sex Marital Ther; 2001; 27(5):625-8. PubMed ID: 11554228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peer commentaries on Binik (2005).
    Arch Sex Behav; 2005 Feb; 34(1):23-61. PubMed ID: 15772768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.